Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Generic drug

Methenamine Mandelate

Medicare prescription drug cost, prescriptions and prescribers, 2024

$632K

Medicare cost, 2024

Medicare drug plans spent $632,066 on Methenamine Mandelate in 2024, for 5,946 prescriptions and refills filled by 1,836 patients. Spending fell 20% from 2023 to 2024. California accounts for the most spending ($69,976, 11% of the total).

Medicare cost, 2024

$632K

-19.6% from 2023

Prescriptions

5,946

$106.30 per claim

Patients

1,836

1,750 prescribers

Total spending, 2024

$633K

$344.62 per patient

Questions and answers

How much does Medicare spend on Methenamine Mandelate?

Medicare prescription drug plans paid $632K for Methenamine Mandelate in 2024, for 5,946 prescriptions and refills to 1,836 patients (down 19.6% from 2023). The average cost per claim was $106.30.

Which state spends the most on Methenamine Mandelate?

California had the highest Medicare cost for Methenamine Mandelate in 2024: $70K for 612 claims, followed by Pennsylvania ($64K).

Who prescribes Methenamine Mandelate the most?

Sandra L Lindholm-Norman, nurse practitioner in Walnut Creek, CA, had the highest Medicare cost for Methenamine Mandelate in 2024: 12 claims costing $6,492.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Methenamine Mandelate was $633K in 2024, after a high of $997K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Methenamine Mandelate, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Sandra L Lindholm-Norman Walnut Creek, CANurse Practitioner12Under 11$6,492
William A Morton Waycross, GAInternal Medicine95Under 11$3,639
Surinder Pal Ardsley, NYInternal Medicine12Under 11$2,798
Paul D Mumma Crooksville, OHFamily Practice11Under 11$2,708
Michael R Evankovich Erie, PAUrology24Under 11$2,676
Frank J Costa Monroeville, PAUrology15Under 11$2,463
Jose A Rivera Sepulveda Statesboro, GAInternal Medicine44Under 11$2,396
Akkil Ali Tamarac, FLInternal Medicine15Under 11$2,368
Nicholas J Modjeski Winona, MNFamily Practice13Under 11$2,349
Ali Salem Montclair, CAInternal Medicine14Under 11$2,274
Amanda R Roberts Portland, MEInternal Medicine15Under 11$2,208
Craig W Canfield San Luis Obispo, CAUrology13Under 11$2,167
Caroline McWilliams Mays Landing, NJInternal Medicine34Under 11$2,150
David C Lesseski Fairview, PAFamily Practice17Under 11$2,132
Jill G Bryant Waycross, GAInternal Medicine26Under 11$2,045
Nicole R Caniglia Tucson, AZPhysician Assistant13Under 11$1,994
Austin J Lee Portland, ORStudent in an Organized Health Care Education/Training Program13Under 11$1,994
Jennifer Simmons Bloomsburg, PAUrology15Under 11$1,971
Margaret E Hagan Wichita, KSInfectious Disease12Under 11$1,940
Manuel A Ojeda Miami Beach, FLInternal Medicine18Under 11$1,894
James A Wright Fond Du Lac, WIUrology16Under 11$1,876
Dhimantkumar A Pandya Mount Kisco, NYInternal Medicine11Under 11$1,822
William Y Josephson Northridge, CAInternal Medicine14Under 11$1,800
Margaret M Bismarck Medford, ORNurse Practitioner11Under 11$1,795
Michael A Ahearn Kewanee, ILHospitalist19Under 11$1,697

Prescriber data by year

YearPrescribersClaimsPatientsCost
20222,0607,9462,244$785K
20232,2679,1102,481$786K
20241,7505,9461,836$632K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Chartwell Rx Ll3,163$364K
Edenbridge/Dexc2,672$259K
Seton Pharmaceu120$10K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
15
RxNorm concept IDs
2741045, 992153, 992184

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube